Aikido Pharma Inc.(AIKI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AIKI Aikido Pharma Inc.

Market Closed 12-21 16:00:00 EST

3.56

+0.00

0.00%

High3.56	Low3.56	Vol0.00
Open3.56	D1 Closing3.56	Amplitude0.00%
Mkt Cap18.30M	Tradable Cap15.61M	Total Shares5.14M
T/O115.01K	T/O Rate0.00%	Tradable Shares4.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AIKI","market":"US","secType":"STK","nameCN":"Aikido Pharma Inc.","latestPrice":3.56,"timestamp":1671656400000,"preClose":3.56,"halted":8,"volume":0,"delay":0,"floatShares":4383654,"shares":5140114,"eps":-3.931902,"marketStatus":"Market Closed","change":0,"latestTime":"12-21 16:00:00 EST","open":3.56,"high":3.56,"low":3.56,"amount":115014.490406,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.931902,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"symbolChange":{"newSymbol":"DOMH","executeDate":"2022-12-22"},"adr":0,"exchange":"NASDAQ","adjPreClose":3.56,"volumeRatio":0},"requestUrl":"/m/hq/s/AIKI","defaultTab":"news","newsList":[{"id":"2293094589","title":"BRIEF-Aikido Pharma Announces Name And Stocker Ticker Symbol Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2293094589","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2293094589?lang=en_us&edition=fundamental","pubTime":"2022-12-22 21:17","pubTimestamp":1671715054,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQ","BOLT","LU1720051108.HKD","LU2357305700.SGD","MNQmain","SQQQ","ON","BK4139",".IXIC","AIKI","BK4512","LU1720051017.SGD","LU1861215975.USD","QLD","QID","DOMH","BK4141","TQQQ","PSQ","LU1861220033.SGD","NQmain","LU1548497426.USD"],"gpt_icon":0},{"id":"2286591389","title":"BRIEF-Aikido Pharma Announces Successful Initial Public Offering Of Asp Isotopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2286591389","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2286591389?lang=en_us&edition=fundamental","pubTime":"2022-11-28 22:03","pubTimestamp":1669644186,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SANA","APR","BK4082","AIKI","BK4196","LABP","LHDX","ASPI","CGEM","BK4007","BK4139"],"gpt_icon":0},{"id":"2272550988","title":"BRIEF-Aikido's share Repurchase Program Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2272550988","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2272550988?lang=en_us&edition=fundamental","pubTime":"2022-10-04 21:28","pubTimestamp":1664890121,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4082","LHDX","BK4023","BK4139","SANA","CGEM","ONTF","LABP","APR","AIKI","BK4196"],"gpt_icon":0},{"id":"2266807490","title":"BRIEF-Dominari Financial Inc Executes Definitive Agreement To Buy Broker-Dealer","url":"https://stock-news.laohu8.com/highlight/detail?id=2266807490","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2266807490?lang=en_us&edition=fundamental","pubTime":"2022-09-10 06:29","pubTimestamp":1662762545,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APR","BK4139","BK4023","ONTF","BK4007","AIKI","CGEM","LABP","SANA","BK4196","BK4082","LHDX"],"gpt_icon":0},{"id":"2260337372","title":"BRIEF-Aikido Pharma Reviewed Proposal From Shalom Auerbach And Determined It Was Not Interested In Pursuing Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2260337372","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2260337372?lang=en_us&edition=fundamental","pubTime":"2022-08-20 05:34","pubTimestamp":1660944860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SANA","AIKI","BK4196","CGEM","LHDX","LABP","APR","ONTF","BK4007","BK4139","BK4023"],"gpt_icon":0},{"id":"2258216882","title":"AIkido Pharma Gets $8/Share Buyout Offer From Shalom Auerbach >AIKI","url":"https://stock-news.laohu8.com/highlight/detail?id=2258216882","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2258216882?lang=en_us&edition=fundamental","pubTime":"2022-08-10 20:48","pubTimestamp":1660135680,"startTime":"0","endTime":"0","summary":"AIkido Pharma Inc. on Wednesday said it received an unsolicited offer from shareholder Shalom Auerbach to acquire the company for about $42 million, or $8 a share.The offer represents a 28% premium to Tuesday's closing price of $6.25 for the New York biotechnology company.AIkido said its board will carefully review the proposal to determine the course of action it believes is in the best interest of the company and its shareholders, adding that it will respond in due course.In a letter to AIkido","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AIKI"],"gpt_icon":0},{"id":"2258628830","title":"BRIEF-Investor Makes Proposal To Acquire Aikido Pharma For $8 Per Share In Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2258628830","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2258628830?lang=en_us&edition=fundamental","pubTime":"2022-08-09 20:34","pubTimestamp":1660048478,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIKI","BK4139"],"gpt_icon":0},{"id":"2253723552","title":"Press Release: AIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2253723552","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2253723552?lang=en_us&edition=fundamental","pubTime":"2022-07-21 21:30","pubTimestamp":1658410200,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRCT","AIKI","FWRG","BK4183","BK4139","TERN","ALVU","OLPX","BK4191","BK4167","BK4007","BK4539","HCTI","BK4209","BOLT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aikidopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.052752},{"month":2,"riseRate":0.404762,"avgChangeRate":0.02568},{"month":3,"riseRate":0.487805,"avgChangeRate":0.023866},{"month":4,"riseRate":0.47619,"avgChangeRate":0.089764},{"month":5,"riseRate":0.372093,"avgChangeRate":-0.017665},{"month":6,"riseRate":0.255814,"avgChangeRate":-0.027633},{"month":7,"riseRate":0.232558,"avgChangeRate":-0.045639},{"month":8,"riseRate":0.372093,"avgChangeRate":-0.016462},{"month":9,"riseRate":0.395349,"avgChangeRate":0.011156},{"month":10,"riseRate":0.27907,"avgChangeRate":-0.04649},{"month":11,"riseRate":0.372093,"avgChangeRate":-0.008838},{"month":12,"riseRate":0.372093,"avgChangeRate":-0.008143}],"exchange":"NASDAQ","name":"Aikido Pharma Inc.","nameEN":"Aikido Pharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aikido Pharma Inc.(AIKI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aikido Pharma Inc.(AIKI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aikido Pharma Inc.,AIKI,Aikido Pharma Inc.股票,Aikido Pharma Inc.股票老虎,Aikido Pharma Inc.股票老虎国际,Aikido Pharma Inc.行情,Aikido Pharma Inc.股票行情,Aikido Pharma Inc.股价,Aikido Pharma Inc.股市,Aikido Pharma Inc.股票价格,Aikido Pharma Inc.股票交易,Aikido Pharma Inc.股票购买,Aikido Pharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aikido Pharma Inc.(AIKI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aikido Pharma Inc.(AIKI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}